CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 160 filers reported holding CRISPR THERAPEUTICS AG in Q4 2018. The put-call ratio across all filers is 1.91 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $241,610 | -18.1% | 5,323 | +1.3% | 0.00% | 0.0% |
Q2 2023 | $294,959 | +12.2% | 5,254 | -9.6% | 0.00% | 0.0% |
Q1 2023 | $262,786 | -15.6% | 5,810 | -24.2% | 0.00% | 0.0% |
Q4 2022 | $311,501 | -38.9% | 7,663 | -1.8% | 0.00% | -50.0% |
Q3 2022 | $510,000 | +16.7% | 7,804 | +8.5% | 0.00% | +100.0% |
Q2 2022 | $437,000 | -27.4% | 7,194 | -24.9% | 0.00% | 0.0% |
Q1 2022 | $602,000 | -26.3% | 9,585 | -11.1% | 0.00% | -50.0% |
Q4 2021 | $817,000 | -55.2% | 10,776 | -33.8% | 0.00% | -60.0% |
Q3 2021 | $1,822,000 | -17.3% | 16,278 | +19.6% | 0.01% | -16.7% |
Q2 2021 | $2,204,000 | +73.5% | 13,614 | +30.7% | 0.01% | +50.0% |
Q1 2021 | $1,270,000 | -23.9% | 10,420 | -4.4% | 0.00% | -33.3% |
Q4 2020 | $1,669,000 | +76.4% | 10,903 | -3.6% | 0.01% | +50.0% |
Q3 2020 | $946,000 | +31.9% | 11,308 | +16.0% | 0.00% | 0.0% |
Q2 2020 | $717,000 | +106.0% | 9,751 | +19.0% | 0.00% | +33.3% |
Q1 2020 | $348,000 | -55.6% | 8,195 | -36.3% | 0.00% | -25.0% |
Q4 2019 | $783,000 | +29.0% | 12,856 | -13.1% | 0.00% | +33.3% |
Q3 2019 | $607,000 | -16.5% | 14,797 | -4.2% | 0.00% | -25.0% |
Q2 2019 | $727,000 | +14.7% | 15,442 | -13.1% | 0.00% | 0.0% |
Q1 2019 | $634,000 | +25.5% | 17,760 | +0.5% | 0.00% | 0.0% |
Q4 2018 | $505,000 | -41.3% | 17,665 | -9.0% | 0.00% | -33.3% |
Q3 2018 | $861,000 | -26.1% | 19,404 | -2.1% | 0.01% | -25.0% |
Q2 2018 | $1,165,000 | +19.7% | 19,830 | -6.8% | 0.01% | +33.3% |
Q1 2018 | $973,000 | +87.5% | 21,277 | -3.7% | 0.01% | +50.0% |
Q4 2017 | $519,000 | – | 22,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 508,558 | $82,330,000 | 27.28% |
Valiant Capital Management, L.P. | 307,700 | $49,814,000 | 3.74% |
NEA Management Company, LLC | 1,590,002 | $257,405,000 | 3.35% |
NIA IMPACT ADVISORS, LLC | 39,891 | $6,458,000 | 3.15% |
Ikarian Capital, LLC | 200,000 | $32,379,000 | 2.62% |
Soleus Capital Management, L.P. | 103,114 | $16,693,000 | 2.57% |
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 157,334 | $25,471,000 | 2.47% |
Capital Impact Advisors, LLC | 45,440 | $7,356,000 | 2.37% |
ARK Investment Management | 7,776,119 | $1,258,876,000 | 2.34% |
Sassicaia Capital Advisers LLC | 13,513 | $2,188,000 | 2.28% |